Ficha del valor · trimestre archivado
ASND
Ascendis Pharma A/S · Healthcare · Biotechnology
15Tenedores rastreados
0Δ titulares
10.69MAcciones mantenidas
$2.13BValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -1.1% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +15 | 28.56M | $7.62B | +25 | −10 |
| Q1 2026 | 92 | -6 | 28.38M | $6.48B | +8 | −14 |
| Q4 2025 | 96 | -1 | 34.58M | $7.37B | — | −1 |
| Q3 2025 | 15 | 0 | 10.69M | $2.13B | +1 | −1 |
| Q2 2025 | 12 | -2 | 9.16M | $1.58B | — | −2 |
| Q1 2025 | 12 | +1 | 5.48M | $853.40M | +1 | — |
| Q4 2024 | 11 | -2 | 5.30M | $729.95M | — | −2 |
| Q3 2024 | 12 | +1 | 6.24M | $930.97M | +2 | −1 |
| Q2 2024 | 11 | — | 7.02M | $958.03M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.73M | -8.0% | $343.19M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 653.01K | — | $129.83M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 653.01K | — | $129.83M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 41 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 42 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 43 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 44 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | BlackRock ✦ (pasivo) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Two Sigma Investments ✦ | 183.89K | +5803.2% | $36.56M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 56 | Millennium Management ✦ | 174.60K | +139.6% | $34.71M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Geode Capital Management ✦ (pasivo) | 68.05K | +11.9% | $13.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 58 | State Street Global Advisors ✦ (pasivo) | 61.54K | +5.7% | $12.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 59 | Arrowstreet Capital ✦ | 60.66K | Nuevo | $12.06M | 0.0% | New | 1 | SEC ↗ |
| 60 | Citadel Advisors ✦ | 27.64K | -95.3% | $5.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 61 | Citadel Advisors ✦ | 27.64K | -95.3% | $5.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 62 | Marshall Wace ✦ | 17.70K | -84.9% | $3.52M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 63 | Marshall Wace ✦ | 17.70K | -84.9% | $3.52M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 64 | D. E. Shaw & Co. ✦ | 3.59K | -50.1% | $712,933 | 0.0% | ▼ Trim | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Arrowstreet Capital | $12.06M | 0.0% |
Posición cerrada
| Adage Capital Partners | $79.33M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 8 tenedores, 7.94M acciones, $34.76M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Aug 14
BIENAIME JEAN JACQUES
Director · 1.10K acc. @ 245.85 · $270,435
Aug 14
BIENAIME JEAN JACQUES
Director · 900 acc. @ 246.91 · $222,219
Ventas en mercado abierto (S)
Sin ventas en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
Aug 13
SC 13G/A — Artisan Partners Limited Partnership
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API